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to determine the diagnostic accuracy of the ED doctor, the cardiologist and
the resident in cardiology using a pocket-size ultrasound (pSU) as an addi-
tional tool, versus the final diagnosis, in patients referred for dyspnea in
the ED.
Methods Between February 2014 and April 2014, patients presenting at the
emergency room in the ED with dyspnea were included. They underwent
physical examination, ECG, routine laboratory tests including BNP and chest
X-ray. The ED doctor and cardiologist gave their diagnosis based on these
data. The resident in cardiology performed an examination using the pSU-
pocket-size ultrasound (pUS) and gave his diagnosis, blinded from the pre-
vious diagnoses. Sensitivity, specificity, negative (NPV) and positive
predictive values (PPV) of the 3 primary diagnoses, were compared to the
diagnosis at the time of hospital discharge.
Results Thirty patients (18 men, 42.6 + 14.6 years) were included in this
pilot study. Examination by pSUUS took 10.3 minutes (IQR= 8.7-11.4). Final
diagnosis was heart failure in 20 patients, infectious pneumonitis in 2 patients,
mixed cardio-respiratory decompensation in 2 patients, pulmonary embolism
in 4 patients and an other diagnosis in 2 patients. For the diagnosis of heart
failure, the ED doctor had a sensitivity, specificity, NPV and PPV values of
50.0, 90.0, 90.9 and 47.4% respectively; the cardiologist 80.0, 90.0, 94.1 and
69.2%; and the resident in cardiology with pocket-size ultrasound had 100,
90.0, 95.2 and 100%, respectively.
Conclusion Our pilot study demonstrated that the use of pocket-size
ultrasound in patients with dyspnea in the ED improved the diagnostic
accuracy of the cause of acute dyspnea. Further and larger studies are
needed before implementing the care of such patients with such ultraport-
able devices.
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The purpose of this study was to determine pulmonary vascular capaci-
tance (PVC) using tricuspid regurgitation and to assess its prognostic value in
pulmonary arterial hypertension (PAH).
PVC assessed by echocardiography using pulmonary regurgitation (PR)
predicts mortality in PAH patients. However, the PR is not accessible in most
patients whereas tricuspid regurgitation (TR) is a quite accessible flow.
Capacitance was measured as the ration of stroke volume divided by pul-
monary pulse pressure (SV/PP). We retrospectively gathered data on 53 PAH
and 29 chronic thromboembolic pulmonary hypertension (CTEPH) patients
who underwent right heart catheterization (RHC), echocardiography and car-
diac magnetic resonance (CMR) in a delay less than 48h. Non-invasive mea-
sure of PVC was correlated with invasive measure and was further analyzed
as a predictor of mortality.
Non-invasive and invasive measures of PVC were well correlated
(r=0.635; p<0.001) and had a good agreement. The echocardiographic PVC
presented a strong negative correlation with invasive pulmonary vascular
resistance (PVR) (r=–0.679; p<0.001). PVC did not predict mortality on a
mean follow-up of 3.2 years. Predictors of mortality in a multivariate analysis
were right atrium pressure (RAP), right ventricle myocardial performance
index (RVMPI) and 6-Minute walk distance (6-MWD).
The PVC as assessed by SV/PP was easily obtained by echocardiography
using TR and was well correlated with invasive measure of PVC. However,
PVC did not predict mortality. RAP, RV myocardial performance index and
6MWD were only independent predictors of outcome.
